Scarica l'app Stockscreener
0.8166
5.64%
0.0436
Dopo l'orario di chiusura:
.82
0.0034
+0.42%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché ITRM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.773
Aprire:
$0.82
Volume 24 ore:
1.39M
Relative Volume:
1.94
Capitalizzazione di mercato:
$36.47M
Reddito:
-
Utile/perdita netta:
$-35.58M
Rapporto P/E:
-0.3082
EPS:
-2.65
Flusso di cassa netto:
$-42.82M
1 W Prestazione:
+16.66%
1M Prestazione:
-27.73%
6M Prestazione:
-45.56%
1 anno Prestazione:
-30.21%
Intervallo 1D:
$0.8082
$0.8581
Intervallo di 1 settimana:
$0.6801
$0.8581
Portata 52W:
$0.6573
$3.02
Iterum Therapeutics Plc Stock (ITRM) Company Profile
Nome
Iterum Therapeutics Plc
Settore
Industria
Telefono
(872) 225-6077
Indirizzo
3 DUBLIN LANDINGS, DUBLIN 1
Confronta ITRM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ITRM
Iterum Therapeutics Plc
|
0.8166 | 34.52M | 0 | -35.58M | -42.82M | -2.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-05-28 | Aggiornamento | Gabelli & Co | Sell → Hold |
| 2021-03-15 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-06-02 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-01-21 | Downgrade | Gabelli & Co | Buy → Sell |
| 2019-12-11 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-06-21 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Iterum Therapeutics Plc Borsa (ITRM) Ultime notizie
Using data filters to optimize entry into Iterum Therapeutics plcMarket Risk Analysis & Smart Allocation Stock Reports - Newser
Will Iterum Therapeutics plc continue its uptrendLong Setup & Safe Capital Growth Stock Tips - Newser
Iterum Therapeutics plc stock trend outlook and recovery path2025 Retail Activity & Technical Buy Zone Confirmations - Newser
Analyzing Iterum Therapeutics plc with multi timeframe chartsGap Down & Weekly Top Performers Watchlists - Newser
Chart based exit strategy for Iterum Therapeutics plc2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - Newser
Price momentum metrics for Iterum Therapeutics plc explainedJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - Newser
What’s next for Iterum Therapeutics plc stock priceLow Risk Stock Trade Opportunity Analysis - Newser
What institutional flow reveals about Iterum Therapeutics plcPattern Recognition Based Market Move Prediction - Newser
Using economic indicators to assess Iterum Therapeutics plc potentialStock Market Watch with Smart Filters - Newser
Advanced analytics toolkit walkthrough for Iterum Therapeutics plcSmart Trend Analysis With Buy Point Cues - Newser
Iterum therapeutics (ITRM) director Dunne buys $10,854 in shares - Investing.com
Iterum therapeutics (ITRM) director Dunne buys $10,854 in shares By Investing.com - Investing.com Australia
Iterum Therapeutics Director Dunne Buys 15,000 Shares at $0.72/Share on Aug 8. - AInvest
Real time pattern detection on Iterum Therapeutics plc stockSecure Buy Strategy Based on Risk Parameters - Newser
Why Iterum Therapeutics plc stock attracts strong analyst attentionLow Drawdown Picks with Weekly Updates - Newser
Developing predictive dashboards with Iterum Therapeutics plc dataFuture Growth Stock Forecasting Strategy - Newser
Will Iterum Therapeutics plc stock recover after recent dropReal Stock Picks With Setup Verification - Newser
Using Bollinger Bands to evaluate Iterum Therapeutics plcTrade Alert System with Volume Analysis - Newser
Iterum Therapeutics plc (NASDAQ:ITRM) Q2 2025 Earnings Call Transcript - MSN
Iterum Therapeutics (NASDAQ:ITRM) Downgraded by Wall Street Zen to “Sell” - Defense World
Iterum Therapeutics PLC (NASDAQ:ITRM) Short Interest Up 54.6% in July - Defense World
ITRM Reports Results - AOL.com
ITRM Reports Results - The Motley Fool
Iterum Therapeutics PLC reports results for the quarter ended June 30Earnings Summary - TradingView
Iterum Therapeutics (ITRM) Financial Outlook for 2025 - GuruFocus
Iterum Therapeutics plc SEC 10-Q Report - TradingView
Iterum Therapeutics reports Q2 results, launches ORLYNVAH, extends cash runway to 2026. - AInvest
Iterum Therapeutics to Launch ORLYNVAH™ for Uncomplicated UTIs in August 2025, Reports Q2 Financial Results - Quiver Quantitative
Iterum Therapeutics reports Q2 revenue, cash runway into 2026, ORLYNVAH launch in August. - AInvest
Iterum Earnings Show $13M Cash as Revolutionary UTI Antibiotic ORLYNVAH Readies for Historic Launch - Stock Titan
Iterum Therapeutics (NASDAQ:ITRM) Shares Down 2.5% – Here’s Why - Defense World
Iterum Therapeutics to Announce Q2 2025 Earnings on Aug 5, 2025 - AInvest
Iterum Therapeutics Q2 Earnings Preview: Analysts Expect EPS of $-0.13 - AInvest
How to forecast Iterum Therapeutics plc trends using time seriesBull Market Summary and Recovery Outlook - Newser
What makes Iterum Therapeutics plc stock price move sharplyFree Accurate Technical Trend Reversal Picks - Newser
Exit strategy if you’re trapped in Iterum Therapeutics plcWealth Accumulation Outlook for Safe Investors - Newser
Is Iterum Therapeutics plc showing signs of accumulationHigh Yield Watchlist with Filtered Picks - Newser
How volatile is Iterum Therapeutics plc stock compared to the marketAchieve rapid financial growth with expert help - Jammu Links News
What are the technical indicators suggesting about Iterum Therapeutics plcTremendous portfolio expansion - Jammu Links News
What is the dividend policy of Iterum Therapeutics plc stockTremendous financial leverage - Jammu Links News
Is Iterum Therapeutics plc a growth stock or a value stockBreakneck growth rates - Jammu Links News
What drives Iterum Therapeutics plc stock priceAchieve consistent profits with smart trading - Jammu Links News
What is the risk reward ratio of investing in Iterum Therapeutics plc stockGet timely advice on market trends - Jammu Links News
What catalysts could drive Iterum Therapeutics plc stock higher in 2025Access high-yield investment alerts now - Jammu Links News
What institutional investors are buying Iterum Therapeutics plc stockAchieve consistent profits with disciplined trading - Jammu Links News
Iterum Therapeutics Plc Azioni (ITRM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):